Related Experiment Videos
[In clinical practice]
Bertrand Delaisi1, Michèle Gérardin
1Service de pédiatrie Hôpital Robert-Debré 75019 Paris. bertrand.delaisi@rdb.ap-hop-paris.fr
La Revue Du Praticien
|April 1, 2003
Summary
No abstract available in PubMed .
Related Concept Videos
You might also read
Related Articles
Articles linked to this work by shared authors, journal, and citation graph.
Sort by
Same author
Impact of Liquid Sublingual Immunotherapy on Health Care Resource Use in Allergic Rhinitis and Asthma in the Real-world EfficAPSI Study.
Journal of investigational allergology & clinical immunology·2025
Same author
Correction to "Impact of liquid sublingual immunotherapy on asthma onset and progression in patients with allergic rhinitis: a nationwide population-based study (EfficAPSI study)" [The Lancet Regional Health - Europe 41 (2024) 100915].
The Lancet regional health. Europe·2024
Same author
Impact of liquid sublingual immunotherapy on asthma onset and progression in patients with allergic rhinitis: a nationwide population-based study (EfficAPSI study).
The Lancet regional health. Europe·2024
Same author
Lumacaftor/Ivacaftor Population Pharmacokinetics in Pediatric Patients with Cystic Fibrosis: A First Step Toward Personalized Therapy.
Clinical pharmacokinetics·2024
Same author
A successful linkage of a named patient products of sublingual immunotherapy-dispensing registry to French healthcare insurance database (SNDS): methodological constitution of the EfficAPSI cohort.
Expert review of clinical immunology·2023
Same author
Use of 2,6-diaminopurine as a potent suppressor of UGA premature stop codons in cystic fibrosis.
Molecular therapy : the journal of the American Society of Gene Therapy·2023
Same journal
[Management of antiplatelet agents and oral anticoagulants in cases of gastrointestinal bleeding].
La Revue du praticien·2026